A perimenopausal woman on Pap smear has repoed ASCUS (atypical squamous cell of unknown significance). Next line of management is:

Okay, let's tackle this question about a perimenopausal woman with ASCUS on a Pap smear. First, I need to recall the standard management for ASCUS. The core concept here is cervical cancer screening and management of abnormal Pap smears. The main thing being tested is the appropriate follow-up for ASCUS.

ASCUS stands for Atypical Squamous Cells of Undetermined Significance. According to guidelines, the next step is typically to perform a high-risk HPV test. If the HPV test is positive, then a colposcopy is needed. If it's negative, repeat the Pap smear in a certain timeframe. But wait, what's the exact protocol? For women over 30, HPV co-testing is common. For younger women, maybe immediate colposcopy? Wait, the patient is perimenopausal, so likely over 30. So the correct next step would be HPV testing first.

Now, looking at the options. The correct answer should be HPV testing. Let's say the options are A: HPV testing, B: Colposcopy, C: Repeat Pap in 6 months, D: Repeat Pap in 12 months. Then the correct answer is A. The other options are incorrect because colposcopy is for positive HPV, repeating Pap too soon might miss changes. The clinical pearl is that ASCUS with HPV positive leads to colposcopy; negative leads to repeat Pap in 12 months for those over 30. For younger women, maybe different, but the question says perimenopausal, so older, so HPV testing is first.

**Core Concept**
ASCUS (Atypical Squamous Cells of Undetermined Significance) on Pap smear indicates mild cervical cell abnormalities. The key principle is determining the risk of high-grade cervical intraepithelial neoplasia (CIN) via high-risk human papillomavirus (HPV) testing, as HPV 16/18 are causally linked to cervical cancer.

**Why the Correct Answer is Right**
Perimenopausal women with ASCUS should undergo **high-risk HPV testing** (e.g., HPV 16/18 subtyping). If HPV-positive, colposcopy is required to visualize and biopsy suspicious lesions. If HPV-negative, repeat Pap smear in 12 months is sufficient, as low-grade changes often regress. This approach avoids unnecessary colposcopy in HPV-negative cases.

**Why Each Wrong Option is Incorrect**
**Option B: Colposcopy** – Reserved for HPV-positive ASCUS or higher-grade cytology (e.g., LSIL, HSIL). Immediate colposcopy in HPV-negative cases increases false positives and over-treatment.
**Option C: Repeat Pap in 6 months** – Not recommended for HPV-negative ASCUS; 12-month follow-up is standard to allow natural regression of transient infections.
**Option D: Treat with antiviral drugs** – No antiviral therapy exists for HPV; management focuses on monitoring and excision of precancerous lesions.

**Clinical Pearl / High-Yield Fact**
ASCUS + HPV 16/18 → colposcopy; ASCUS + other HPV types → repeat Pap in 6 months. Always link cytology results to HPV status for accurate triage. Avoid over-testing in HPV-negative cases.

**Correct Answer: A. High-risk HPV testing**

✓ Correct Answer: C. Colposcopy